Sam Dunning's first feature-length film, “Canoe Dig It?” is a mockumentary-comedy focusing on a freestyle Canoe competition ...

Left winger André Burakovsky struggled in the second half of this season, and now faces the possibility of the Chicago ...

The new Merchant API gives advertisers more scalable, feature-rich tools to manage product data while preparing for the ...

I can't document this, but I do believe it is up there in that 300 ft weave where we first invented the term mass. David Crew is confident Boston is better today because it rid itself of this highway ...

China has spent decades executing a deliberate strategy to corner global critical mineral supply chains. They mine. They process. They stockpile. While they are building the future, we are debating ...

Office Scripts in Excel offer a structured way to automate repetitive tasks, making it easier to manage large datasets or streamline workflows. Built into the “Automate” tab of Excel’s ribbon, this ...

“Too many women’s scripts never even get a read,” co-founder Jan Kimbrough says. “We exist to change that." By Kimberly Nordyke Managing Editor, Digital The Women’s List, a nonprofit organization ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

Drivers who failed to dig out while the snow from our late-January storm was still soft are now contending with thick walls of ice cocooning their vehicles. And while there’s something almost ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...